Home Compare HOLX vs SOLV
Stock Comparison · Industry comparison · Medical Instruments & Supplies

Hologic vs Solventum: Which Stock Looks Stronger in 2026?

Structurally, Hologic and Solventum are closely matched — neither holds a meaningful edge overall. Solventum still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Hologic holds the more constructive position.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

On stability, the clearer edge sits with Hologic, Inc., while the broader score remains level.

INDUSTRY COMPARISON

Both operate in: Medical Instruments & Supplies

This comparison is based on industry proximity, not on functional trajectory similarity. HOLX and SOLV share the same industry classification.

For a similarity-based comparison, see how Hologic and Solventum each position within their functional peer groups in AssetNext.

Peer-Relative Score
HOLX
Hologic, Inc.
70
Peer-Score
Signal qualityHigh
vs
SOLV
Solventum Corporation
70
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: HOLX vs SOLV Profitability 75 74 Stability 90 58 Valuation 67 88 Growth 46 49 HOLX SOLV
Gap Ranking
#1 Stability +32
#2 Valuation +21
#3 Growth +3
#4 Profitability +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for HOLX and SOLV Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer HOLXSOLV Relative valuation Structural strength

Hologic, Inc. still looks stronger overall, though current pricing looks more supportive for Solventum Corporation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Both rank well on stability, but Hologic, Inc. still holds a clear edge.
Valuation
On valuation, the edge still sits with Solventum Corporation, even though both profiles look solid.
Stability — Dominant Gap
HOLX
90
SOLV
58
Gap+32in favour of HOLX

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Solventum, with a forward P/E that is 6.3 turns lower there.

What this means for the comparison

Stability provides the clearer read here, while the broader score remains level.

Explore full peer positioning in AssetNext

Break down the HOLX vs SOLV comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how HOLX and SOLV each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.